StageZero Life Sciences Ltd. Stock price
Equities
SZLS
CA8525403017
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | -9.09% | +11.11% | +11.11% |
Nov. 21 | North American Morning Briefing : All Eyes on -2- | DJ |
Nov. 15 | Transcript : StageZero Life Sciences Ltd., Q3 2023 Earnings Call, Nov 15, 2023 |
Sales 2021 | 5.07M 6.86M | Sales 2022 | 3.8M 5.14M | Capitalization | 4.49M 6.09M |
---|---|---|---|---|---|
Net income 2021 | -7M -9.48M | Net income 2022 | -11M -14.9M | EV / Sales 2021 | 3.99 x |
Net cash position 2021 | 368K 499K | Net Debt 2022 | 1.78M 2.42M | EV / Sales 2022 | 1.65 x |
P/E ratio 2021 |
-2.2
x | P/E ratio 2022 |
-0.39
x | Employees | 40 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 79.63% |
Latest transcript on StageZero Life Sciences Ltd.
1 day | -9.09% | ||
1 week | +11.11% | ||
Current month | +11.11% | ||
1 month | +25.00% | ||
3 months | +11.11% | ||
6 months | -9.09% | ||
Current year | +11.11% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01-12-31 | |
Rebecca Greco
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 97-12-31 |
Garth MacRae
BRD | Director/Board Member | 90 | 99-12-31 |
Chief Executive Officer | - | 01-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.05 | -9.09% | 136,000 |
24-03-27 | 0.055 | +22.22% | 238,979 |
24-03-25 | 0.045 | 0.00% | 26,875 |
24-03-21 | 0.045 | +12.50% | 4,000 |
24-03-20 | 0.04 | -11.11% | 10,110 |
Delayed Quote Toronto S.E., March 28, 2024 at 10:34 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+11.11% | 4.56M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |